Key result
Intensive pharmacist intervention fails to increase statin prescribing compared with an educational manual alone.
Why the study?
Many patients with established cardiovascular disease do not receive statins despite proven benefits, creating a need for effective implementation of secondary prevention guidelines.
Does an intensive pharmacist-led implementation programme increase statin prescribing for secondary prevention in primary care patients with established cardiovascular disease compared to an educational manual alone?
RCT
Cluster randomized
Yes
Does an intensive pharmacist-led implementation programme increase statin prescribing for secondary prevention in primary care patients with established cardiovascular disease compared to an educational manual alone?
An intensive pharmacist-led implementation program nearly doubled GP review of statin eligibility for secondary prevention (19.7% vs. 10.8%, P = 0.023) but failed to increase actual statin prescribing at 6 months (5.8% vs. 5.3%, P = 0.104).
Answers are grounded in this paper and cite their sources.
Intensive pharmacist-led programs do not warrant adoption to increase statin prescribing in primary care CVD; challenges effectiveness of multifaceted implementation over education alone.
BACKGROUND: Although statins have indisputably proven to reduce fatal and nonfatal events in patients with cardiovascular disease, many patients with established cardiovascular disease do not receive them. Research into the effective and efficient implementation of current guidelines on secondary prevention is therefore needed. DESIGN: A cluster randomized implementation trial was conducted between September 2006 and February 2008. METHODS: Experimental pharmacists received an intensive implementation programme, whereas control pharmacists received an educational manual only. Pharmacists in both the groups were asked to identify eligible patients and to provide general practitioners (GPs) with lists of these patients. Physicians received instructions from the pharmacists to review the patients regarding a statin indication and to start a statin when they considered this as appropriate. Main outcome measure was the percentage of identified patients who received one or more statin prescriptions at 6 months follow-up. RESULTS: Although twice as many patients were reviewed for a statin indication by a GP in the experimental group (19.7 vs. 10.8%, P = 0.023), an equally low number of patients in the experimental group and the control group received statins (5.8 vs. 5.3%, P = 0.104). CONCLUSION: The intensive implementation programme had an impact on pharmacists and GPs, but did not result in more patients receiving statins.
No takes yet. Share an insight, caveat, or question.
Gompel et al. (2011) conducted an RCT in Established cardiovascular disease without statin therapy. Intensive pharmacist-led implementation programme vs. Educational manual only for pharmacists (both groups identified eligible patients for GP review) was evaluated on Percentage of identified patients who received one or more statin prescriptions at 6 months follow-up (p=0.104). An intensive pharmacist-led implementation programme did not increase statin prescribing at 6 months compared with an educational manual alone.
Synapse has enriched 10 related papers. Consider them for comparative context: